Biologica Technologies® showcases AMP aesthetic™ at Plastic Surgery The Meeting 2017

Friday, October 6, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

CARLSBAD, Calif., Oct. 6, 2017 /PRNewswire/ -- Biologica Technologies, developers and marketers of Allofill®, announced today

that they will be introducing AMP aesthetic at the upcoming Plastic Surgery The Meeting, the annual conference hosted by the American Society of Plastic Surgeons (ASPS).

AMP aesthetic is the first product of its kind, an allogeneic-derived growth

factor that can be used in the same manner as platelet rich plasma (PRP). The product contains a full cascade of growth factors, including but not limited to; PDGF, TGF-?1, and VEGF. In comparison with market leading PRP systems and the PRP processed, AMP aesthetic possesses sufficiently higher growth factor amounts. Additionally, when AMP aesthetic is combined with autologous fat transfer (AFT), early data has exhibited higher graft retention than AFT alone.

"AMP aesthetic continues our company's commitment of bringing cutting edge tissue-based technologies to the field of aesthetics," stated Scott Cadotte, Vice President of Sales & Marketing of Biologica Technologies. "It provides a cost-effective 'off the shelf' option for plastic surgeons and their patients."

About Biologica TechnologiesFounded in 2015, Biologica Technologies is a privately-held company fully dedicated to improving patients' lives and the health care providers' experience through innovative biologic solutions. Their first aesthetic product, Allofill, is an adipose-derived filler containing naturally occurring growth factors that can be used to fill soft-tissue defects as a noninvasive alternative to autologous fat grafting. The company is headquartered in Carlsbad, CA.

Related Linkswww.biologicatechnologies.comwww.allofill.com

 

View original content:http://www.prnewswire.com/news-releases/biologica-technologies-showcases-amp-aesthetic-at-plastic-surgery-the-meeting-2017-300532346.html

SOURCE Biologica Technologies



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook